The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.

Published

Journal Article

The Antibacterial Resistance Leadership Group (ARLG), with funding from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, was created in June 2013. Its mission is to develop, prioritize, and implement a clinical research agenda that addresses the public health threat of antibacterial resistance. This article reports on the progress that the ARLG has made to date in fulfilling its mission. Since inception, the ARLG has received and reviewed >70 study proposals, initiated >30 studies, executed >300 agreements, included data from >7000 subjects, published >45 manuscripts, and provided opportunities for 26 mentees. Despite this substantial progress, there remains significant work to be accomplished. This article also describes the considerable challenges that lie ahead.

Full Text

Duke Authors

Cited Authors

  • Chambers, HFC; Cross, HR; Evans, SR; Kreiswirth, BN; Fowler, VG; Antibacterial Resistance Leadership Group (ARLG),

Published Date

  • March 15, 2017

Published In

Volume / Issue

  • 64 / suppl_1

Start / End Page

  • S3 - S7

PubMed ID

  • 28350896

Pubmed Central ID

  • 28350896

Electronic International Standard Serial Number (EISSN)

  • 1537-6591

Digital Object Identifier (DOI)

  • 10.1093/cid/ciw824

Language

  • eng

Conference Location

  • United States